Need Help With This Product?
Our specialists are here to help you find the best product for your application.
iCell Endothelial Cells, 11713
Product Overview
Endothelial cells are highly dynamic cells that form the inner lining of blood vessels. In addition to their structural role, endothelial cells regulate the passage of substances between the bloodstream and surrounding tissue. They also secrete mediators that influence vascular hemodynamics, inflammation, cell trafficking, and the remodeling and formation of new blood vessels. Endothelial cell dysfunction is associated with a variety of diseases including atherosclerosis, coronary artery disease, hypertension, and inflammatory disorders.
Derived from human iPS cells, FCDI’s iCell® Endothelial Cells provide a reliable, reproducible, and physiologically relevant source of cells for vascular disease modeling, drug screening, and vascular tissue engineering applications. Benefits include:
- >90% CD31+/CD105+ populations across lots and multiple passages
- VEGF-mediated proliferation, sprouting, migration, and invasion
- TNFα-mediated upregulation of adhesion molecules
- Thrombin-sensitive barrier function
- Acetylated LDL uptake
- Shear stress-induced alignment
- 2D and 3D capillary-like network formation
Broad Function and Application
Assayed as a pure culture or in co-culture with other differentiated cell types to recapitulate native tissue architecture, iCell Endothelial Cells enable a variety of novel applications:
- Vascular tissue engineering:
Decellularized organs Amenable to decellularized organ (e.g. kidney) scaffold approaches (Caralt et al., 2015) - Vascular tissue engineering:
Natural matrices and bioengineering scaffolds Compatible with natural matrix approaches as well as microfluidic device and bioreactor system cultures (Bischel et al. 2014; Belair et al., 2014) - Angiogenesis and wound healing
Providing relevant biology for the study of blood vessel formation and remodeling relevant to cancer, chronic inflammatory, and degenerative diseases - Infectious disease studies
Serving as a novel human in vitro model for the study of bacterial and viral infections
Components:
Our regular business hours are 9:00am to 5:00pm Central Time (USA)
Need Help With This Product?
Our specialists are here to help you find the best product for your application.
Our regular business hours are 9:00am to 5:00pm Central Time (USA)
Technical Docs
PROTOCOLS
Application Notes
Applying Transfection Technologies to Create Novel Screening Models
Application Notes
Assaying Barrier Function
Application Protocols
Assaying Barrier Function: xCELLigence RTCA Cardio System
Application Notes
Assaying Cell Proliferation
USER DOCS
Biosafety Document
iCell Endothelial Cells Biosafety Document
Datasheet
iCell Endothelial Cells
Safety Data Sheet
iCell Cell-Based Products Safety Data Sheet - Asia
Safety Data Sheet
iCell Cell-Based Products Safety Data Sheet - Germany
Safety Data Sheet
iCell Cell-Based Products Safety Data Sheet - North America
User's Guides
iCell Endothelial Cells
Performance Data
iCell Endothelial Cells Purity Demonstrated by Flow Cytometry Analysis
The cells have >90% expression of CD105 (endoglin), CD31 (PECAM-1) and CD144 (VE-cad) as determined by flow cytometry analysis.
Figure 1: iCell Endothelial Cells Are a Highly Pure Population
Figure 2: iCell Endothelial Cells Display Expected Markers and Functions
iCell Endothelial Cell Markers and Functions Assessed by Immunostaining
(A) When immunostained for von Willebrand Factor (vWF), the cells showed characteristic Weibel-Palade body staining. (B) In a thick layer of Matrigel, the cells exhibited the capacity to form tubes. (C) To assess the barrier function, the cells were immunostained for the tight junction protein ZO-1.
Barrier Function Assay Using the xCELLigence RTCA Platform
iCell Endothelial Cells exhibit barrier function activity that can be disrupted by treatment with thrombin and reliably assessed using impedance-based platforms. iCell Endothelial Cells provide an in vitro test system that recapitulates native human endothelium properties and functions while the xCELLigence RTCA Cardio System provides a label-free technology for non-invasive monitoring of cell behavior and viability. The methods and results presented here highlight how to gather relevant data on human endothelial viability and barrier function. Together, iCell Endothelial Cells and impedance-based technologies offer a valuable cell model system for understanding the endothelial barrier characteristics, mechanisms of endothelial barrier dysfunction, and dynamic modulation of the endothelium permeability, enabling a wide range of applications in academic and pharmaceutical research. iCell Endothelial Cells were cultured for 48 hours on the E-Plate in Complete iCell Endothelial Cells Maintenance Medium before the addition of thrombin. (A) The representative Cell Index curves showed the dose-dependent disruption effect of thrombin on the barrier function and the recovery phase. (B) The percentage of Cell Index compared to pre-treatment baseline levels was calculated at the time of thrombin addition, at 9 hours post-treatment, or at 21 hours post-treatment (mean ± SD, n = 2 wells).
Figure 3: Barrier Disruption Effect of Thrombin on iCell Endothelial Cell
Product Highlights
Applications
iCell Endothelial Cells are amenable to a variety of assays including:
- Angiogenesis/Vasculogenesis
- Cell permeability
- Cell adhesion
- Cell proliferation
- Cell invasion
- Impedance/Barrier function
- Cell migration
- Tube formation
Advantages:
- Human cells: iCell Endothelial Cells are differentiated from human iPS cells and exhibit characteristics and functions of endothelial cells. .
- Homogenous and reproducible: iCell Endothelial Cells are highly pure, providing biologically relevant and reproducible results.
- Acute and long-term testing: iCell Endothelial Cells actively proliferate, remaining viable and pure in culture for weeks, enabling assessment of both acute and sub-chronic responses.
- Easy to implement: iCell Endothelial Cells are shipped cryopreserved with cell culture medium supplement specifically formulated for optimal cell performance. Simply thaw and use.
Publications
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells Rieker C, Migliavacca E, Vaucher A, Baud G, Marquis J, Charpagne A, Hegde N, Guignard L, McLachlan M, Pooler AM. (2019) Arterioscler Thromb Vasc Biol.39(9):e195-e207. (2019)
Excess Glutamate Secreted from Astrocytes Drives Upregulation of P-glycoprotein in Endothelial Cells in Amyotrophic Lateral Sclerosis Mohamed LA, Markandaiah SS, Bonanno S, Pasinelli P, and Trotti D. (2019) Exp Neurol. 316:27-38 (2019)
Human Vascular Tissue Models Formed from Human Induced Pluripotent Stem Cell Derived Endothelial Cells Belair DG, Whisler JA, Valdez J, Velazquez J, Molenda JA, Vickerman V, Lewis R, Daigh C, Hansen TD, Mann DA, Thomson JA, Griffith LG, Kamm RD, Schwartz MP, and Murphy WL (2015) Stem Cell Rev Rep 11(3):511-25. doi: 10.1007/s12015-014-9549-5. (2015)
Optimization and Critical Evaluation of Decellularization Strategies to Develop Renal Extracellular Matrix Scaffolds As Biological Templates for Organ Engineering and Transplantation Caralt M, Uzarski JS, Iacob S, Obergfell KP, Berg N, Bijonowski BM, Kiefer KM, Ward HH, Wandinger-Ness A, Miller WM, Zhang ZJ, Abecassis MM, and Wertheim JA (2014) Am J Transplant 15(1):64-75 (2014)
Vascular Tissue Engineering: Building Perfusable Vasculature for Implantation Gui L and Niklason LE (2014) Curr Opin Chem Eng 3:68-74 (2014)
Diabetes Mellitus Aggravates Hemorrhagic Transformation after Ischemic Stroke via Mitochondrial Defects Mishiro K, Imai T, Sugitani S, Kitashoji A, Suzuki Y, Takagi T, Chen H, Oumi Y, Tsuruma K, Shimazawa M, Hara H PLoS One. (2014) 9(8): e103818. (2014)